Cargando…
CD2 Immunobiology
The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and anti...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295915/ https://www.ncbi.nlm.nih.gov/pubmed/32582179 http://dx.doi.org/10.3389/fimmu.2020.01090 |
_version_ | 1783546737782161408 |
---|---|
author | Binder, Christian Cvetkovski, Filip Sellberg, Felix Berg, Stefan Paternina Visbal, Horacio Sachs, David H. Berglund, Erik Berglund, David |
author_facet | Binder, Christian Cvetkovski, Filip Sellberg, Felix Berg, Stefan Paternina Visbal, Horacio Sachs, David H. Berglund, Erik Berglund, David |
author_sort | Binder, Christian |
collection | PubMed |
description | The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro and clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is a missed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation. |
format | Online Article Text |
id | pubmed-7295915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72959152020-06-23 CD2 Immunobiology Binder, Christian Cvetkovski, Filip Sellberg, Felix Berg, Stefan Paternina Visbal, Horacio Sachs, David H. Berglund, Erik Berglund, David Front Immunol Immunology The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro and clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is a missed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation. Frontiers Media S.A. 2020-06-09 /pmc/articles/PMC7295915/ /pubmed/32582179 http://dx.doi.org/10.3389/fimmu.2020.01090 Text en Copyright © 2020 Binder, Cvetkovski, Sellberg, Berg, Paternina Visbal, Sachs, Berglund and Berglund. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Binder, Christian Cvetkovski, Filip Sellberg, Felix Berg, Stefan Paternina Visbal, Horacio Sachs, David H. Berglund, Erik Berglund, David CD2 Immunobiology |
title | CD2 Immunobiology |
title_full | CD2 Immunobiology |
title_fullStr | CD2 Immunobiology |
title_full_unstemmed | CD2 Immunobiology |
title_short | CD2 Immunobiology |
title_sort | cd2 immunobiology |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295915/ https://www.ncbi.nlm.nih.gov/pubmed/32582179 http://dx.doi.org/10.3389/fimmu.2020.01090 |
work_keys_str_mv | AT binderchristian cd2immunobiology AT cvetkovskifilip cd2immunobiology AT sellbergfelix cd2immunobiology AT bergstefan cd2immunobiology AT paterninavisbalhoracio cd2immunobiology AT sachsdavidh cd2immunobiology AT berglunderik cd2immunobiology AT berglunddavid cd2immunobiology |